Monthly Communication Report

Corporation:	GlaxoSmithKline
Associated registration:	953603-5088-57
Communication date:	2023-09-20
Posted date:	2023-10-16

Designated Public Office Holders who participated in the communication:	Joel Denis, Director General Vaccine Supply and Assurance, Public Health Agency of Canada (PHAC) Simon Kennedy, Deputy Minister Innovation, Science and Economic Development Canada (ISED) Rodrigo Arancibia, Director Life Science Industries Directorate, Innovation, Science and Economic Development Canada (ISED) Darryl  Patterson, Director General Biomanufacturing Strategy Implementation Team, Innovation, Science and Economic Development Canada (ISED) Kasondra White, Director Office of Life Sciences and Biomanufacturing Readiness, Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:	Economic Development,  Health
Responsible Officer who filed this communication report:	Sridhar Venkatesh
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.